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▼Who has not encountered the problem? You want to sub-
clone a cDNA from one vector into another (for example
from a cloning vector into an eukaryotic expression vector),
but the multiple cloning sites (MCS) of the two vectors are
not compatible or are in opposite orientations, or there are
also potential restriction sites in the insert sequence. The
simple TA method of cloning a polymerase chain reaction
(PCR)-generated DNA fragment with 3′ A overhangs into
a vector with 5′ overhangs can be used to overcome such
problems (Ref. 1). Native Taq polymerase has an enzymatic
activity that is capable of adding an adenosine monophos-
phate residue to the 3′ end of newly synthesized DNA
fragments (Ref. 2). This enzyme activity is used in the TA
cloning strategy (Ref. 1) in which a vector with a 5′ protrud-
ing thymidine monophosphate residue is used for cloning
DNA fragments that are generated by PCR (Figure 1). How-
ever, in addition to being able to fill in any 5′ protruding
ends that are generated by restriction enzymes (generally
by Klenow enzyme), Taq polymerase can then add an ad-
ditional adenosine residue, making these DNA fragments
suitable for the TA cloning strategy in either orientation. It
is therefore possible to obtain clones with the insert in that
orientation in the TA cloning vector necessary for further
subcloning into another vector, for example a eukaryotic or
bacterial expression vector. This method has been used for
subcloning human 5-hydroxytryptamine transporter cDNA
(Ref. 3) that is inserted in the vector pGEM4Z (Promega) and
then into the eukaryotic expression vector p cDNA 3 (Invit-
rogen), which does not posses a blue/white (lacZ) selection
system and therefore makes it very inefficient to subclone
DNA with the same restriction site at both ends because
the empty vector is religated if it is not dephosphorylated
beforehand.
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Protocol
2 µg of pGEM4Z containing the cDNA in the Hind III site
of the MCS were digested with Hind III to separate
the cDNA from the vector. Following agarose gel elec-
trophoresis (0.8% agarose, 1×TBE, 0.00005% ethidium
bromide) the 2 kb cDNA bandwas cut out of the gel and
the DNA was isolated by centrifugation of the agarose
slice through a gene elute column (Sigma) for 10 min
at 12 000 g.
The DNA-containing elute was further purified by
phenol/chloroform/isoamyl-alcohol (25:24:1) extrac-
tion, chloroform/isoamylalcohol (24:1) extraction and
then ethanol precipitation. After a final wash of the
DNA pellet with 70% ethanol, the dried pellet was
dissolved in 49 µl of standard PCR mixture without
primers (20 mM Tris-HCl pH 8.4, 50 mM KCl, 2 mM
MgCl2 and 0.2 mM each of dNTPs). 1 µl (5 U) of Taq
polymerase (Gibco BRL) was added and the mixture
was incubated for 10 min at 72◦C to fill in the restric-
tion sites (blunting) and to add an additional 3′ adeno-
sine residue. 2 µl of this reaction were used for ligation
with the vector pCR2.1 (Invitrogen) according to the
user manual of the TA Cloning Kit (Invitrogen).
Following transformation and plating of bacteria accord-
ing to the kit manual, plasmid mini-preparations were
performed with the Plasmid Mini Kit (Quiagen) and
clones with the desired orientation were detected by
restriction analysis with Apa I, which cuts once in the
MCS of pCR2.1 and once asymmetrically in the cDNA,
after agarose electrophoresis.
Insert-DNA from a clone with the correct orientation
for further subcloning and expression in p cDNA
3 (Invitrogen) was separated from pCR2.1 by Hind
III/Xba I digestion and then subcloned into the Hind
III/Xba I-digested vector pcDNA3. The pcDNA3 vector
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FIGURE 1. Schematic representation of the TA cloning strategy using Taq polymerase.
(Invitrogen) is also available directly as a TA cloning
vector, which enables the end-modified cDNA to be
subcloned directly into pcDNA3.
In principle, this method allows the rapid subcloning of
any DNAwith 5′ protruding ends first into a TA cloning vec-
tor and then in the desired orientation into another vector.
This is a great time-saving method as there is no need to se-
quence the entire insert-cDNA again because only the cDNA
ends are processed by Taq polymerase and no newly gen-
erated Taq-based errors can occur. This method is also suit-
able for the generation of genomic libraries. A TA cloning
vector has the advantage that a relative low background of
religated empty vector can be used compared with a vector
cut by only one restriction enzyme or with other methods
using adaptor ligation to genomic fragments. In addition,
this method prevents the possible religation of genomic
DNA fragments that are generated by restriction digestion.
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Products Used
cDNA: cDNA from Clontech Inc
Taq DNA polymerase: Taq DNA polymerase from
PE Applied Biosystems
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Promega Corporation
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Pharmacia
Taq polymerase: Taq polymerase from Bioline
Taq polymerase: Taq polymerase from Advanced
Biotechnologies
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Bioline
vector pCR2.1: vector pCR2.1 from Invitrogen
TA Cloning Kit: TA Cloning Kit from Invitrogen
plasmid mini system: plasmid mini system from
QIAGEN GmbH
cDNA: cDNA from Clontech Inc
pcDNA3: pcDNA3 from Invitrogen
cDNA: cDNA from Clontech Inc
pcDNA3: pcDNA3 from Invitrogen
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